Catheter-Based Treatment of Ventricular Tachycardia: Procedural Outcomes, Recurrence Predictors, and Safety in Contemporary Electrophysiology Practice

doi:N/A

Bangaldesh Journal of Cardivascular Medicine

2025, Volume 3, Issue 2 : 1-4

Research Article

Catheter-Based Treatment of Ventricular Tachycardia: Procedural Outcomes, Recurrence Predictors, and Safety in Contemporary Electrophysiology Practice

Arif Rahman

Nusrat Jahan

Mahmud Hasan

Farhana Akter

⁴

. Kamal Uddin

⁵

Department of Electrophysiology, National Heart Institute, Dhaka, Bangladesh

Department of Cardiology, Bangladesh Medical University, Dhaka, Bangladesh

Department of Cardiac Imaging, Chattogram Medical College, Bangladesh

⁴

Department of Internal Medicine, South Asia Medical Institute, Dhaka, Bangladesh

⁵

Department of Cardiovascular Research, Eastern Heart Centre, Dhaka, Bangladesh

Abstract

Background: Ventricular tachycardia (VT) is a life-threatening arrhythmia associated with sudden cardiac death, recurrent hospitalization, and implantable cardioverter-defibrillator shocks. Catheter ablation has emerged as an important therapeutic strategy for drug-refractory VT and recurrent ICD therapy.

Objective: To evaluate procedural success, recurrence rates, complications, and predictors of outcome following catheter-based treatment of VT.

Methods: A prospective observational study was conducted among 214 patients undergoing catheter ablation for sustained monomorphic VT between January 2022 and December 2024. Clinical characteristics, substrate type, mapping strategy, ablation approach, acute success, complications, and 12-month outcomes were analyzed.

Results: Ischemic cardiomyopathy was present in 58.4%, non-ischemic cardiomyopathy in 28.5%, and idiopathic VT in 13.1%. Acute procedural success was achieved in 82.7%. VT recurrence occurred in 24.8% during 12-month follow-up. Major complications occurred in 5.1%. Independent predictors of recurrence included LVEF <35%, non-ischemic substrate, multiple inducible VT morphologies, and incomplete substrate modification.

Conclusion: Catheter-based treatment of VT is effective and reasonably safe in contemporary electrophysiology practice. Outcomes are best in idiopathic VT and ischemic scar-related VT with complete substrate modification. Advanced structural heart disease remains associated with higher recurrence risk.

Keywords

Ventricular tachycardia

Catheter ablation

Electrophysiology

ICD shocks

Scar-related VT

Substrate modification

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.

Bangladesh J. Cardiovasc. Med. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.

Recommended Articles

Drug-Coated Balloons in Peripheral Vascular Interventions

Michael R. Anderson,

Sarah T. Bennett,

Ahmed K. Rahman,

Priya Sharma,

David L. Cooper

1-6

Predictors of Recurrence After Atrial Fibrillation Ablation

Michael R. Anderson,

Sarah L. Thompson,

Ahmed K. Rahman,